Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Mol Carcinog. 2020 Apr 15;59(8):886–896. doi: 10.1002/mc.23200

Figure 1: Screening of compounds for KRAS binding efficiency.

Figure 1:

Figure 1 shows surface representations of Apo-KRAS (PDB# 4EPR) binding with small molecules as assessed by using a Glide software. Each surface representation is appended with PubChem ID and binding energy is represented in Kcal/mol.